Testifying before a U.S. Senate panel, USC health policy expert Paul Ginsburg said that health insurance mega-mergers such as those sought by Aetna and Anthem are extremely complex, difficult to analyze and could cost consumers.
Ginsburg spoke before lawmakers from the Senate Committee on the Judiciary’s Subcommittee on Antitrust, Competition Policy and Consumer Rights Sept. 22. Joining Ginsburg as witnesses were Mark Bertolini, chairman and CEO of Aetna Inc.; Joseph Swedish, president and CEO of Anthem Inc.; Leemore Dafny, research professor in hospital and health services at Northwestern University; Richard Pollack, president and CEO of the American Hospitals Association; and George Slover, senior policy counsel at Consumers Union.
Will consumers save?
For more than two decades, Ginsburg has studied how changes in the financing and delivery of health care affect people. Explaining why the health insurance market is so complex, he said insurers sell to different market segments, including individuals, Medicare beneficiaries and national corporations — in many distinct geographic areas. Additionally, the companies act as intermediaries, buying from health providers and selling insurance to consumers.
Ginsburg acknowledged potential upsides.
“For one, Wall Street analysts believe that these mergers will lead to substantial reductions in administrative costs,” he said.
But will consumers see those savings in their premiums?
Paul Ginsburg, center, testifies at a Senate hearing. (Photo/Paul Morigi)
“We may believe that a merger will lower prices paid to providers, but we then need to analyze whether fees will be passed on to those buying insurance,” he said.
Chief executives of the insurance companies assured the Judiciary Committee’s antitrust subcommittee that consumers will win from the proposed mergers.
“Better health insurance to more people,” said Swedish, whose company Anthem wants to acquire Cigna for $48 billion.
He and Bertolini, CEO of Aetna, which has agreed to buy Humana and its huge Medicare Advantage business for $37 billion, insisted that fewer, bigger insurance companies will expand competition, improve health care and lower prices.
When asked to assess the Affordable Care Act’s impact on the mergers, Ginsburg said the provisions that do come into play “should be seen in a positive light,” even if they contribute to the urge to merge. The ACA encourages insurers to become more efficient and spurs experimentation in methods of payment, moving away from the traditional fee-for-service model.
Ginsburg is director of public policy at the Leonard D. Schaeffer Center for Health Policy and Economics and is holder of the Norman Topping Chair in Medicine and Public Policy at the USC Price School of Public Policy. An economist, he founded the Center for Studying Health System Change and served as president from 1995 to 2013.
The ultimate arbiter
The Department of Justice — not Congress — ultimately will decide whether to allow the insurance deals. It will conduct a detailed analysis of the possible effects of the mergers and may require the firms to divest some operations, as Anthem had to do in 2012 before buying Amerigroup. The department holds this data private.
“Without being privy to this analysis, I do not have a position concerning whether or not these mergers should be approved,” Ginsburg said. He and Dafny both said they wished the data would be made public.
Given the significance of the insurance sector to our wallets and to the functioning of our health care system, the public deserves better data.
“Given the significance of the insurance sector to our wallets and to the functioning of our health care system, the public deserves better data,” Dafny said.
The antitrust subcommittee rarely tackles health issues, but subcommittee chairman Sen. Mike Lee (R-Utah) said he called the hearing to help the public and lawmakers understand the consolidation trend in the health care industry and how it may affect consumers.
How the mergers may affect the 90 million people — three out of 10 Americans — who have insurance through the four companies was on the mind of Sen. Amy Klobuchar (D-Minn.), the top Democrat on the subcommittee.
“I want to make sure that these deals do not harm consumers by increasing premiums or reducing benefits,” she said.
Sen. Richard Blumenthal (D-Conn.) said he’s “deeply concerned about these mergers.”
Slover also noted that stakes for consumers are high.
“There are strong indicators, to us, that these mergers could create too much concentration in too many markets and cause too much harm to consumer choice,” Slover said.
Pollack said the mergers “could be a blow to millions of health consumers, as well as the hospitals, doctors and others who are working to improve quality and efficiency while making care more affordable to patients.”
For Ginsburg, who has testified as an expert witness at dozens of Congressional hearings over the last 35 years, the morning policy discussion was a departure from the contentious political tone of other hearings on Capitol Hill.
“My main message was trying to broaden the discussion — to think not only about consolidation or these mergers but ways to make insurance markets more competitive and how to pursue alternative payment models,” he said after the hearing.